4.4 Article

An MD2 Hot-Spot-Mimicking Peptide that Suppresses TLR4-Mediated Inflammatory Response in vitro and in vivo

Journal

CHEMBIOCHEM
Volume 12, Issue 12, Pages 1827-1831

Publisher

WILEY-V C H VERLAG GMBH
DOI: 10.1002/cbic.201100211

Keywords

analgesics; inhibitors; myeloid differentiation factors; peptidomimetics; toll-like receptorsn

Funding

  1. National Institutes of Health [DA026950, DA025740, NS067425, RR025780, DA029119, DA023132, DA024044]
  2. University of Colorado [NIH T32 GM-065103]
  3. Australian National Health and Medical Research Council [465423]
  4. Australian Research Council [DP110100297]

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Cell Biology

Effects of Mild and Moderate Monoclonal Antibody Dose on Inflammation, Bone Loss, and Activation of the Central Nervous System in a Female Collagen Antibody-induced Arthritis Mouse Model

Bonnie Williams, Florence Lees, Helen Tsangari, Mark R. Hutchinson, Egon Perilli, Tania N. Crotti

Summary: This study aimed to compare macroscopic and microscopic changes in the paws, along with central nervous system activation between a mild and moderate CAIA model. The moderate CAIA dose induced significantly greater local paw inflammation, inflammatory cell infiltration, and glial reactivity within the brain compared to the mild CAIA model. These findings support the use of a moderate CAIA model to induce more consistent histopathological features without excessive joint destruction.

JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2021)

Article Neurosciences

Neuroimmunological complications arising from chemotherapy-induced gut toxicity and opioid exposure in female dark agouti rats

Juliana Esma Bajic, Gordon Stanley Howarth, Suzanne Mashtoub, Alexandra Louise Whittaker, Larisa Bobrovskaya, Mark Rowland Hutchinson

Summary: This study investigates the effects of different analgesics on central glial reactivity and proinflammatory changes in rats with chemotherapy-induced gut toxicity (CIGT). While carprofen and buprenorphine showed beneficial effects in ameliorating neuroimmune responses, tramadol presented complications and may not be optimal in managing pain associated with CIGT. The findings suggest potential mechanisms contributing to cancer symptom clusters and have implications for optimal pain management in this setting.

JOURNAL OF NEUROSCIENCE RESEARCH (2022)

Article Agriculture, Dairy & Animal Science

Evaluation of miRNA as Biomarkers of Emotional Valence in Pigs

Laura Marsh, Mark R. Hutchinson, Clive McLaughlan, Stefan T. Musolino, Michelle L. Hebart, Robyn Terry, Paul J. Verma, Stefan Hiendleder, Alexandra L. Whittaker

Summary: The study found that circulating miRNA in pigs is not an effective biomarker for emotional state. The challenge remains that current physiological and behavioral indices are either unable to distinguish between positive and negative emotional states, or they are simply not suitable for a production environment.

ANIMALS (2021)

Review Biochemical Research Methods

Intrathecal implantation surgical considerations in rodents; a review

Azim Arman, Mark R. Hutchinson

Summary: This review discusses the major surgical approaches applicable for intrathecal implantation in rodents, along with associated side effects and important preoperative and postoperative considerations.

JOURNAL OF NEUROSCIENCE METHODS (2021)

Article Neurosciences

Autofluorescent imprint of chronic constriction nerve injury identified by deep learning

Martin E. Gosnell, Vasiliki Staikopoulos, Ayad G. Anwer, Saabah B. Mahbub, Mark R. Hutchinson, Sanam Mustafa, Ewa M. Goldys

Summary: This study successfully validated the feasibility of using hyperspectral autofluorescence imaging and deep learning techniques as a tool to differentiate tissues from nerve injured vs non-injured mice, providing important research and clinical applications prospects.

NEUROBIOLOGY OF DISEASE (2021)

Review Pharmacology & Pharmacy

TLR4 biased small molecule modulators

Cong Lin, Hongshuang Wang, Miyuan Zhang, Sanam Mustafa, Yibo Wang, Hongyuan Li, Hang Yin, Mark R. Hutchinson, Xiaohui Wang

Summary: Biased pharmacological modulators offer potential therapeutic benefits by targeting specific receptors with increased efficiency and reduced adverse effects. While biased signaling modulators targeting GPCRs have received attention, the modulation of non-GPCR receptors remains to be explored, including Toll-like receptor 4 (TLR4). Discovery of biased modulators of TLR4 not only provides insights for future development but also potential drug candidates for other non-GPCR receptors.

PHARMACOLOGY & THERAPEUTICS (2021)

Article Immunology

Toll-like receptors change morphine-induced antinociception, tolerance and dependence: Studies using male and female TLR and signalling gene KO mice

Jacob H. L. Thomas, Liang Lui, Andrew Abell, William Tieu, Andrew A. Somogyi, Juliana E. Bajic, Mark R. Hutchinson

Summary: The study found that reducing TLR signaling pathway can enhance acute analgesic effects, but only male TIR8 deficient mice showed less morphine analgesia. TLR2 and TLR4 deficient mice can prevent analgesic tolerance, but MyD88 animals cannot. Withdrawal behaviors are only protected in TLR2(-/-) mice.

BRAIN BEHAVIOR AND IMMUNITY (2022)

Review Medicine, General & Internal

Glial-modulating agents for the treatment of pain: protocol for a systematic review

Ian Gilron, Maggie Z. X. Xiao, Marielle Balanaser, Meg Carley, Nader Ghasemlou, Michael W. Salter, Mark R. Hutchinson, Dwight E. Moulin, R. Andrew Moore, Amanda Ross-White

Summary: This planned systematic review aims to evaluate the efficacy and adverse effects of glial-modulating drugs in pain management. The study will conduct a detailed search on multiple databases and assess the quality and potential bias of included studies using specific criteria. The findings will provide valuable guidance for pain management strategies.

BMJ OPEN (2022)

Review Neurosciences

The Neuroimmune Interface and Chronic Pain Through the Lens of Production Animals

Charlotte H. Johnston, Alexandra L. Whittaker, Samantha H. Franklin, Mark R. Hutchinson

Summary: Communication between the central nervous system and the immune system is crucial for the development of chronic pain. Measuring pathological pain state in production animals is challenging, limiting our understanding of chronic pain in animals. Further research into the neuroimmune interface in production animals will benefit human clinical pain management and animal husbandry practices.

FRONTIERS IN NEUROSCIENCE (2022)

Article Medicine, General & Internal

Study protocol: an observational study of distress, immune function and persistent pain in HIV

Victoria J. Madden, Ncumisa Msolo, Luyanduthando Mqadi, Maia Lesosky, Gillian J. Bedwell, Mark R. Hutchinson, Jonathan Grant Peter, Romy Parker, Andrew Schrepf, Robert R. Edwards, John A. Joska

Summary: This study aims to investigate the relationship between distress, pain, and inflammatory reactivity in HIV-infected individuals. The findings will contribute to a better understanding of pain-related diseases and may lead to new treatment options.

BMJ OPEN (2022)

Letter Clinical Neurology

Considering Precision and Utility When we Talk About Pain. Comment on Cohen et al

Graham L. Moseley, Neil Pearson, Roland Reezigt, Victoria J. Madden, Mark R. Hutchinson, Martin Dunbar, Anneke J. Beetsma, Hayley B. Leake, Pete Moore, Laura Simons, Lauren Heathcote, Cormac Ryan, Carolyn Berryman, Amelia K. Mardon, Benedict M. Wand

JOURNAL OF PAIN (2023)

Article Biochemistry & Molecular Biology

Long-term intrathecal administration of morphine vs. baclofen: Differences in CSF glycoconjugate profiles using multiglycomics

Edward S. X. Moh, Krishnatej Nishtala, Sameera Iqbal, Vasiliki Staikopoulos, Dilip Kapur, Mark R. Hutchinson, Nicolle H. Packer

Summary: The use of opioids for persistent pain treatment has increased, but it has not improved pain management outcomes. This study investigated the molecular mechanisms of opioids by analyzing proteomics and multiglycomics of cerebral spinal fluid samples from patients receiving long-term intrathecal morphine or baclofen. The study found significant differences in polysialic acid, heparan sulfate glycosaminoglycan, and O-glycan profiles between the two treatment groups, revealing previously undescribed molecular effects of opioid administration and pain management.

GLYCOBIOLOGY (2022)

Review Sport Sciences

Evolving Expectations of the Orthopedic Team Physician: Managing the Sidelines and Landmines

Timothy L. Miller, Grant L. Jones, Mark Hutchinson, Dharmesh Vyas, James Borchers

Summary: The role of orthopedic team physicians has evolved greatly over the past decade, requiring them to adapt to various challenges and meet the needs and expectations of athlete-patients. With increasing media scrutiny, their work has become more complex and important, and their responsibilities continue to evolve to ensure their relevance and necessity.

CURRENT SPORTS MEDICINE REPORTS (2021)

Article Multidisciplinary Sciences

Nicotine and its metabolite cotinine target MD2 and inhibit TLR4 signaling

Hongyuan Li, Yinghua Peng, Cong Lin, Xiaozheng Zhang, Tianshu Zhang, Yibo Wang, Yuanpeng Li, Siru Wu, Hongshuang Wang, Mark R. Hutchinson, Linda R. Watkins, Xiaohui Wang

Summary: The study shows that nicotine and its metabolite cotinine inhibit TLR4 via targeting MD2, thus suppressing neuroinflammation, independent of classic neuronal nicotinic acetylcholine receptors.

INNOVATION (2021)

Review Public, Environmental & Occupational Health

Androgens, Endometriosis and Pain

Susan F. Evans, M. Louise Hull, Mark R. Hutchinson, Paul E. Rolan

Summary: This research delves into the relationship between androgens, endometriosis, and chronic pain, revealing a strong inverse correlation between androgen levels and pelvic and period pain. The study also suggests the potential for alleviating pain by optimizing androgen levels in the treatment of these conditions.

FRONTIERS IN REPRODUCTIVE HEALTH (2021)

No Data Available